Extended Submission Deadline: 21 October, 2015
Email not displaying correctly? View it in your browser

We are pleased to announce that the deadline for abstract submission for ATTD 2016 has been extended.

If you have not yet submitted your abstract there is still time to share your latest research and contribute to the future of the field.

Why should I submit an abstract?

  1. ATTD is an unparalleled opportunity to present your work on today’s most cutting-edge topics connected to diabetes-related technology
  2. ATTD is a unique platform for the exchange of views on current issues with your professional peers and the distinguished international speakers
  3. All accepted abstracts are published in the peer-reviewed journal Diabetes Technology & Therapeutics, published by Mary Ann Liebert, Inc., Publishers

Take a leading role by submitting your abstract now!

Extended Submission Deadline: 21 October, 2015


Here are 3 reasons to book your accommodation directly with ATTD:

  1. Save Time: We provide you with the information you need such as the hotel distance from the venue
  2. Save Money: Competitive rates to ensure ATTD participants receive the best deals
  3. On-Site Assistance: Our accommodation team is available now and at the venue for any problems or queries you might have

Conference Organizer

Rue François-Versonnex 7, 1207 Geneva, Switzerland
www.kenes.com | info@kenes.com
© ATTD 2016 | Kenes Group Ltd. All rights reserved.
Contact Us Unsubscribe